ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
General Health & Fitness
Health & Wellness
Rare, super coronavirus antibodies
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="DragonBits" data-source="post: 180486" data-attributes="member: 18023"><p>Rare, super coronavirus antibodies likely to yield vaccine, say Stanford, UCSF experts</p><p></p><p>By Peter Fimrite Updated 11:24 am PDT, Tuesday, June 16, 2020</p><p> </p><p>Dr. Katharina Roeltgen cleans COVID-19 antibody tests at the Stanford Clinical Virology Lab in Palo Alto. The lab is conducting antibody tests to try to neutralize COVID-19. Photo: James Tensuan / Special To The Chronicle</p><p>Photo: James Tensuan / Special To The Chronicle</p><p></p><p>Dr. Katharina Roeltgen cleans COVID-19 antibody tests at the Stanford Clinical Virology Lab in Palo Alto. The lab is conducting antibody tests to try to neutralize COVID-19.</p><p></p><p>The discovery of antibodies that block the most infectious elements of the coronavirus is helping Bay Area scientists unlock the many mysteries of human immunity, and could be crucial in the development of a vaccine.</p><p></p><p>Epidemiologists have found “neutralizing antibodies” in fewer than 5% of COVID-19 patients, but the ones they are now attempting to isolate are unique in their ability to prevent SARS-CoV-2 — the specific coronavirus that causes the illness — from entering human cells.</p><p></p><p>It means anyone with these antibodies would almost certainly be immune to the disease and that their blood plasma could potentially be used to inoculate others, according to several studies published over the past month by research laboratories in the United States and China.</p><p></p><p>Dr. George Rutherford, a UCSF infectious disease specialist, said neutralizing antibodies attack the virus’ crown-like spikes, which are the genesis of the name “corona,” preventing them from poking into and hijacking human cells.</p><p></p><p>This particular antibody prevents “the key from going into the lock,” Rutherford said, referring to the spike proteins, which must latch onto a human cell before the parasitic virus can replicate itself. “That’s what you want if you are going to have immunity.”</p><p></p><p>The super-strength antibody is one of many discoveries over the past three months by scientists in laboratories, hospitals and universities searching for a way to neutralize COVID-19. One thing that’s clear from the research is how inconsistent the human immune system is. Researchers say, for instance, that while some infected people develop killer antibodies, others have no antibodies at all.</p><p></p><p>Dr. George Rutherford, a UCSF infectious disease specialist, says certain antibodies attack the virus’ crown-like spikes. Photo: Santiago Mejia / The Chronicle</p><p></p><p>Photo: Santiago Mejia / The ChronicleDr. George Rutherford, a UCSF infectious disease specialist, says certain antibodies attack the virus’ crown-like spikes.</p><p></p><p>Between 10% and 20% of patients with COVID-19 show no antibodies in serological tests, Rutherford said. The remaining 75% or more of coronavirus patients develop antibodies, he said, but they aren’t the neutralizing kind, indicating immunity to the disease might not last long in most people.</p><p></p><p>“The way I think about it, we have a certain amount of the population that, even if they have a history of infection, won’t have any measurable antibodies and therefore won’t have immunity,” Rutherford said. “Then there is a certain proportion who will have high levels of antibodies and some who have transient antibodies, where we don’t know how long those antibodies will last.”</p><p></p><p>[URL unfurl="true"]https://www.sfgate.com/health/article/Rare-super-coronavirus-antibodies-likely-to-15339594.php?t=a9de34bb77[/URL]</p></blockquote><p></p>
[QUOTE="DragonBits, post: 180486, member: 18023"] Rare, super coronavirus antibodies likely to yield vaccine, say Stanford, UCSF experts By Peter Fimrite Updated 11:24 am PDT, Tuesday, June 16, 2020 Dr. Katharina Roeltgen cleans COVID-19 antibody tests at the Stanford Clinical Virology Lab in Palo Alto. The lab is conducting antibody tests to try to neutralize COVID-19. Photo: James Tensuan / Special To The Chronicle Photo: James Tensuan / Special To The Chronicle Dr. Katharina Roeltgen cleans COVID-19 antibody tests at the Stanford Clinical Virology Lab in Palo Alto. The lab is conducting antibody tests to try to neutralize COVID-19. The discovery of antibodies that block the most infectious elements of the coronavirus is helping Bay Area scientists unlock the many mysteries of human immunity, and could be crucial in the development of a vaccine. Epidemiologists have found “neutralizing antibodies” in fewer than 5% of COVID-19 patients, but the ones they are now attempting to isolate are unique in their ability to prevent SARS-CoV-2 — the specific coronavirus that causes the illness — from entering human cells. It means anyone with these antibodies would almost certainly be immune to the disease and that their blood plasma could potentially be used to inoculate others, according to several studies published over the past month by research laboratories in the United States and China. Dr. George Rutherford, a UCSF infectious disease specialist, said neutralizing antibodies attack the virus’ crown-like spikes, which are the genesis of the name “corona,” preventing them from poking into and hijacking human cells. This particular antibody prevents “the key from going into the lock,” Rutherford said, referring to the spike proteins, which must latch onto a human cell before the parasitic virus can replicate itself. “That’s what you want if you are going to have immunity.” The super-strength antibody is one of many discoveries over the past three months by scientists in laboratories, hospitals and universities searching for a way to neutralize COVID-19. One thing that’s clear from the research is how inconsistent the human immune system is. Researchers say, for instance, that while some infected people develop killer antibodies, others have no antibodies at all. Dr. George Rutherford, a UCSF infectious disease specialist, says certain antibodies attack the virus’ crown-like spikes. Photo: Santiago Mejia / The Chronicle Photo: Santiago Mejia / The ChronicleDr. George Rutherford, a UCSF infectious disease specialist, says certain antibodies attack the virus’ crown-like spikes. Between 10% and 20% of patients with COVID-19 show no antibodies in serological tests, Rutherford said. The remaining 75% or more of coronavirus patients develop antibodies, he said, but they aren’t the neutralizing kind, indicating immunity to the disease might not last long in most people. “The way I think about it, we have a certain amount of the population that, even if they have a history of infection, won’t have any measurable antibodies and therefore won’t have immunity,” Rutherford said. “Then there is a certain proportion who will have high levels of antibodies and some who have transient antibodies, where we don’t know how long those antibodies will last.” [URL unfurl="true"]https://www.sfgate.com/health/article/Rare-super-coronavirus-antibodies-likely-to-15339594.php?t=a9de34bb77[/URL] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
General Health & Fitness
Health & Wellness
Rare, super coronavirus antibodies
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top